253 related articles for article (PubMed ID: 8884963)
21. Characteristics of dose-response relationships for late radiation effects: an analysis of skin telangiectasia and of head and neck morbidity.
Turesson I
Radiother Oncol; 1991 Mar; 20(3):149-58. PubMed ID: 1852906
[TBL] [Abstract][Full Text] [Related]
22. Evidence for individual differences in the radiosensitivity of human skin.
Tucker SL; Turesson I; Thames HD
Eur J Cancer; 1992; 28A(11):1783-91. PubMed ID: 1389511
[TBL] [Abstract][Full Text] [Related]
23. Acute radiation reaction and local control in breast cancer patients treated with postmastectomy radiotherapy.
Kuhnt T; Richter C; Enke H; Dunst J
Strahlenther Onkol; 1998 May; 174(5):257-61. PubMed ID: 9614954
[TBL] [Abstract][Full Text] [Related]
24. Clonogenic survival and cytokinesis-blocked binucleation of skin fibroblasts and normal tissue complications in soft tissue sarcoma patients treated with preoperative radiotherapy.
Akudugu JM; Bell RS; Catton C; Davis AM; O'Sullivan B; Waldron J; Wunder JS; Hill RP
Radiother Oncol; 2004 Jul; 72(1):103-12. PubMed ID: 15236882
[TBL] [Abstract][Full Text] [Related]
25. Fibroblast radiosensitivity in vitro and lung fibrosis in vivo: comparison between a fibrosis-prone and fibrosis-resistant mouse strain.
Dileto CL; Travis EL
Radiat Res; 1996 Jul; 146(1):61-7. PubMed ID: 8677299
[TBL] [Abstract][Full Text] [Related]
26. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study.
Bentzen SM; Thames HD; Overgaard M
Radiother Oncol; 1989 Jul; 15(3):267-74. PubMed ID: 2772254
[TBL] [Abstract][Full Text] [Related]
27. Relationship between radiosensitivity and normal tissue complications in Saudi cancer patients treated with radiotherapy.
Alsbeih G; El-Sebaie M; El-Rajhi N; Allam A; Al-Buhairi M; Al-Harbi N; Khafaga Y; Alsubael M; Al-Shabanah M
J Egypt Natl Canc Inst; 2004 Dec; 16(4):216-23. PubMed ID: 16116498
[TBL] [Abstract][Full Text] [Related]
28. The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules.
Burnet NG; Nyman J; Turesson I; Wurm R; Yarnold JR; Peacock JH
Radiother Oncol; 1994 Dec; 33(3):228-38. PubMed ID: 7716263
[TBL] [Abstract][Full Text] [Related]
29. Radiosensitivity of dermal and tumor fibroblasts derived from the same patient.
Honkanen J; Rantanen V; Kulmala J; Grénman R; Klemi P; Pekkola K
J Cancer Res Clin Oncol; 1998; 124(8):415-20. PubMed ID: 9750017
[TBL] [Abstract][Full Text] [Related]
30. Association of CD4
Veldwijk MR; Seibold P; Botma A; Helmbold I; Sperk E; Giordano FA; Gürth N; Kirchner A; Behrens S; Wenz F; Chang-Claude J; Herskind C
Clin Cancer Res; 2019 Jan; 25(2):562-572. PubMed ID: 30327309
[TBL] [Abstract][Full Text] [Related]
31. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
[TBL] [Abstract][Full Text] [Related]
32. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
Mackay RI; Hendry JH
Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
[TBL] [Abstract][Full Text] [Related]
33. Does the interval between fractions matter in the range of 4-8 h in radiotherapy? A study of acute and late human skin reactions.
Nyman J; Turesson I
Radiother Oncol; 1995 Mar; 34(3):171-8. PubMed ID: 7631023
[TBL] [Abstract][Full Text] [Related]
34. No correlation between radiosensitivity or double-strand break repair capacity of normal fibroblasts and acute normal tissue reaction after radiotherapy of breast cancer patients.
El-Awady RA; Mahmoud M; Saleh EM; El-Baky HA; Lotayef M; Dahm-Daphi J; Dikomey E
Int J Radiat Biol; 2005 Jul; 81(7):501-8. PubMed ID: 16263653
[TBL] [Abstract][Full Text] [Related]
35. Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy.
Safwat A; Bentzen SM; Turesson I; Hendry JH
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):198-204. PubMed ID: 11777639
[TBL] [Abstract][Full Text] [Related]
36. In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data.
Stausbøl-Grøn B; Bentzen SM; Jørgensen KE; Nielsen OS; Bundgaard T; Overgaard J
Br J Cancer; 1999 Mar; 79(7-8):1074-84. PubMed ID: 10098739
[TBL] [Abstract][Full Text] [Related]
37. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
Bentzen SM; Saunders MI; Dische S
Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
[TBL] [Abstract][Full Text] [Related]
38. In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer.
Rudat V; Dietz A; Conradt C; Weber KJ; Flentje M
Radiother Oncol; 1997 May; 43(2):181-8. PubMed ID: 9192965
[TBL] [Abstract][Full Text] [Related]
39. Comparison between pulsed-field gel electrophoresis and the comet assay as predictive assays for radiosensitivity in fibroblasts.
Sarkaria JN; Bush C; Eady JJ; Peacock JH; Steel GG; Yarnold JR
Radiat Res; 1998 Jul; 150(1):17-22. PubMed ID: 9650597
[TBL] [Abstract][Full Text] [Related]
40. Relationship between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiation reactions: a comparison of training and validation cohorts of breast cancer patients.
Dickson J; Magee B; Stewart A; West CM
Radiother Oncol; 2002 Mar; 62(3):321-6. PubMed ID: 12175563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
